Abstract
Aims/Background-Comparison of the diffusion coefficient through the bloodaqueous barrier of healthy volunteers measured in different cities with identical fluorophotometers using a standardised protocol. Methods-Healthy volunteers aged between 20 and 70 years were studied in seven European cities. The fluorescein concentration in the anterior segment of each eye was measured with a commercial scanning fluorophotometer 30 and 40 minutes after intravenous fluorescein. The decay of non-protein bound fluorescein concentration in blood plasma was determined with the use of three blood samples taken at 7, 15 , and 55 minutes after injection. The diffusion coefficient through the blood-aqueous barrier was calculated from the ratio between the fluorescein concentration in the anterior chamber and the time integral of nonprotein bound fluorescein concentration in plasma using specially developed software.
Results-The mean values of the diffusion coefficient (SD) (XIO-4 min-1) were 4*76 (1.51) (n=20, Brussels), 5*48 (2.33) (n=17, Coimbra), 3*47 (2.09) (n=12, Cologne), 6-09 (2.77) (n=21, Frankfurt), 3 .85 (1.59) (n=11, Ghent), 4*99 (1.69) (n=23, Leiden), and 4-87 (1.05) (n=20, Madrid [356] [357] [358] [359] [360] [361] [362] Quantitative measurements of the bloodaqueous barrier (BAB) permeability or of the diffusion coefficient through the BAB (kd) in humans have been performed previously with fluorophotometry after cataract surgery and intraocular lens implantationl-8 and to study the effects of topical drugs.9-1" The measurements were also performed in diabetic patients,10-'6 in uveitis patients, '7 18 and in patients with retinal vein occlusion'9 or retinal detachment. 20 Various methods and protocols for the quantification of the permeability of the BAB were used which could result in different outcomes. The easier method was to use the concentration of fluorescein in the anterior chamber (in ng/ml), measured at a fixed time (30, 45 , or 60 minutes) after intravenous injection of a fixed amount of fluorescein (7 or 14 mg/kg body weight). 5 where a and ,B are constants depending on subject and amount of fluorescein injected.
Integrating CO(t) from the time of first appearance in the eye (td) up to the time of measurement (tm) yields the time integral Ip(tM):
The diffusion coefficient kd is calculated using equation (2) wherein the value of Cp(tm) corresponds to the peak value of fluorescein concentration in the anterior chamber and the value of the time integral is calculated using equation (4) . K is assumed to be 1 0 and td=54 seconds. (2) Slit-lamp examination of both eyes was performed by an ophthalmologist without the use of fluorescein since this could interfere with the measurements.
(3) Four fluorophotometric (pre-)scans (scan duration about 15 seconds) were performed in each eye for determination of the autofluorescence values of the anterior chamber and the cornea (Fig 1, thin The fluorescein concentration of the latter dilution was measured in a cuvette in front of the fluorophotometer and the NPBF concentration of the sample was calculated.
(2) A power of time regression procedure was applied to the plasma NPBF values and the corresponding sampling times (determination of ot and P in equation (3); Fig 2) .
(3) The mean anterior chamber autofluorescence value of each eye was determined from the prescans (Fig 1) . (3) and (4) with a=27-1 and ,3=0-580.
(4) The peak anterior chamber fluorescence was determined from each measurement scan (Fig 1) and the corresponding mean autofluorescence value was subtracted.
(5) The diffusion coefficient kd was calculated for each measurement scan using equations (2) and (4). (6 Table 3 .
Reproducibility
The mean values and standard deviations of kd measured a second time and the corresponding interval times are presented in Table 4 for each of the four centres that repeated the measurements. The values did not differ significantly from the first ones (double sided Wilcoxon paired test p>0 39).
Differences between centres
The significance of the differences in the values of kd between centres is presented in Table 5 . solid line was obtained using a linear regression procedure to the data points ofthe healthy to be reliable and reproducible provided the controls in aU centres except Cologne. The dotted lines represent the 95% probability protocol was strictly followed. intervalsfor the regression line and the broken lines the 95% probability intervals for the The interval time between the first plasma sample and the fluorescein injection was critical. A time less than about 5 minutes resulted in an inaccurate time of sampling while the fluorescein concentration in plasma was changing rapidly and a time greater than about 9 minutes resulted in an inaccurate first part of the plasma time integral. In both cases the values of kd were unreliable. The data of five volunteers were rejected as a result of incorrect time of the first plasma sample.
One centre (Cologne) demonstrated plasma time integral values largely deviating from the values of the other centres (factor 6-7; p<0 007). On the other hand the values of the diffusion coefficient through the BAB found at this centre did not differ significantly from the other centres except Frankfurt (Table 5 ). This contradiction may be explained by an incorrect calibration of the fluorophotometer in Cologne resulting in apparent excessive fluorescein concentration values in the plasma samples and in the anterior chamber; these errors cancel out in the calculation of the diffusion coefficient.
(One major problem encountered with the Concerted Action study was the time consuming communication between the hospitals in the different countries, mainly caused by language problems.)
